Hydroxyapatite vs fluoride toothpaste
Share with a colleague
Fluoride toothpaste has the larger cavity-prevention evidence base. Compare hydroxyapatite toothpaste trials for cavities, sensitivity, and children's use. Every figure below is taken from the cited source — nothing is estimated or interpolated.
Clinically reviewed by Chithra Durgam, DDS on .
RR 0.98
pooled risk ratio for new or progressing caries lesions in a 2025 review (95% CI 0.85–1.12); the authors found no significant difference, with uncertainty in either direction [2025]
18 months
follow-up in an adult trial of 10% hydroxyapatite versus 1,450 ppm fluoride; 189 adults contributed to the intention-to-treat analysis [2023]
500 ppm
fluoride concentration in the control toothpaste in a childhood hydroxyapatite trial; compare this concentration with the product you recommend [2021]
13 trials
and 609 patients in a 2026 sensitivity review; the authors found different results for tactile and cold-air sensitivity at different follow-ups [2026]
Toothpaste evidence for cavities and sensitivity
Compare the cavity-prevention and sensitivity findings below. Check the toothpaste formulation and follow-up in each study before applying its results to your patient.
| Toothpaste use | Population and comparison | Clinical findings | Counseling point | Source |
|---|---|---|---|---|
| Fluoride toothpaste for cavity prevention | Permanent teeth in children and adolescents; fluoride toothpaste versus non-fluoride controls | Cochrane reviewers found high- or moderate-certainty evidence of fewer new caries with 1,000–1,250 ppm and 1,450–1,500 ppm fluoride toothpastes versus non-fluoride controls. These comparisons underpin fluoride's preventive evidence. Use the hydroxyapatite trials below for comparisons with specific hydroxyapatite formulations. | Established evidence | 2019 |
| Hydroxyapatite toothpaste as a fluoride alternative | 2025 comparative systematic review; new and progressing early caries lesions | The reviewers included four eligible studies and calculated a pooled risk ratio of 0.98 (95% CI 0.85–1.12; p=0.61). They found no significant difference. The confidence interval allows effects in either direction, so assess the tested product and patient population before advising a switch. | Evidence for specific products | 2025 |
| Hydroxyapatite vs fluoride toothpaste in adults | 10% hydroxyapatite versus 1,450 ppm fluoride; change in decayed, missing, and filled surfaces (DMFS) | Researchers recorded no DMFS increase in 89.3% of the hydroxyapatite group and 87.4% of the fluoride group among 171 per-protocol completers. They established non-inferiority using a prespecified margin of 20 percentage points and found no evidence of superiority. Dr. Kurt Wolff and the participating universities funded the study. Apply these findings to the studied products over the 18-month follow-up. | Met the non-inferiority margin | 2023 |
| Hydroxyapatite toothpaste for children | Children aged 3–7; 10% microcrystalline hydroxyapatite versus 500 ppm amine fluoride, brushed three times daily for 336 days | Researchers randomized 214 children; 177 completed per protocol. They found new or progressing ICDAS lesions in 72.7% of children using hydroxyapatite and 74.2% using fluoride, meeting a 20-percentage-point non-inferiority margin. Dr. Kurt Wolff funded the trial. Compare its 500 ppm fluoride control and three-times-daily brushing schedule with the product and routine you advise. The participants were aged 3–7. | Check the fluoride concentration | 2021 |
| Nano hydroxyapatite toothpaste for sensitive teeth | 2026 systematic review of nano-hydroxyapatite versus fluoride; tactile and cold-air sensitivity outcomes | The reviewers found short-term benefits for some nano-hydroxyapatite outcomes and better cold-air sensitivity relief with fluoride at eight weeks. They identified bias concerns in many trials and substantial variation in some pooled outcomes. Consider the patient's sensitivity trigger and the duration of relief. The authors assessed sensitivity rather than cavity prevention. | Results vary by sensitivity trigger | 2026 |
| Nano hydroxyapatite toothpaste safety | SCCS 2025 opinion; specified nano-hydroxyapatite used in oral cosmetics | The SCCS assessed nano-hydroxyapatite as safe up to 29.5% in toothpaste when manufacturers meet its specifications for particle dimensions and aspect ratios, use rod-shaped particles, and leave them uncoated and unmodified. The committee excluded needle-shaped particles. Check the material specification: this opinion addresses ingredient safety, with separate requirements for cavity-prevention claims and US regulatory status. | Check the material specification | 2025 |
| Fluoride toothpaste amounts for children | ADA guidance on fluoride toothpaste amounts and supervision | The ADA recommends a rice-grain-sized smear from the first tooth until age three, then a pea-sized amount from ages three to six. Ask caregivers to supervise brushing and limit swallowing. The ADA requires fluoride for its anticaries Seal. Discuss the child's toothpaste amount and cavity risk when parents ask about fluoride-free toothpaste. | Explain amount and supervision | 2026 |
How to use this table
- Ask whether your patient wants to prevent cavities or relieve sensitivity. Use the findings for that outcome.
- You can tell patients: 'Researchers have found encouraging results for some hydroxyapatite toothpastes. We have a larger evidence base for fluoride in cavity prevention. Let's check the product you're considering against your dental needs.'
- Check whether the manufacturer uses microcrystalline or nano-hydroxyapatite. Match the formulation and concentration to the trial behind the claim.
- Disclose the manufacturer's funding of the adult and childhood trials when discussing their findings.
- Explain the limits of early-lesion remineralization: researchers studying these outcomes have not established that toothpaste can rebuild missing tooth structure.
- Use the handout action below to prepare an explanation for your patient, then review the generated wording against the cited evidence before using it.
How this brief was built
We selected the cited trials, reviews, and professional guidance through a targeted search and checked them on 22 October 2026. We retained each study's population, toothpaste formulation, comparator, and endpoint. We used the abstract for the 2025 caries review and the early online publication for the 2026 sensitivity review. We distinguish a finding of no significant difference from proof of equivalence.
Cited sources
Where every figure comes from
Fluoride toothpastes of different concentrations for preventing dental caries
Cochrane Database of Systematic Reviews · 2019 · Systematic review
Open the sourceThe role of hydroxyapatite-based, fluoride-free toothpastes on the prevention and the remineralization of initial caries lesions: A systematic review and meta-analysis
Journal of Dentistry · 2025 · Systematic review and meta-analysis; abstract assessed
Open the sourceCaries-preventing effect of a hydroxyapatite-toothpaste in adults: a 18-month double-blinded randomized clinical trial
Frontiers in Public Health · 2023 · Randomized non-inferiority trial
Open the sourceImpact of a toothpaste with microcrystalline hydroxyapatite on the occurrence of early childhood caries: a 1-year randomized clinical trial
Scientific Reports · 2021 · Randomized non-inferiority trial
Open the sourceEfficacy comparison of nano-hydroxyapatite and fluoride for dentin hypersensitivity: a systematic review and meta-analysis
BMC Oral Health · 2026 · Systematic review and meta-analysis; early online publication
Open the sourceScientific Opinion on Hydroxyapatite (nano), Submission IV, SCCS/1677/25
European Commission Scientific Committee on Consumer Safety · 2025 · Material-specific safety opinion
Open the sourceToothpastes: anticaries ingredients, children's use, and the ADA Seal
American Dental Association · 2026 · Professional guidance; accessed October 2026
Open the source
Ask this against the live evidence.
This brief is a stored snapshot of the published literature. Run the search yourself for sources matched to the case in front of you.
Share with a colleague
This brief was compiled from the published reviews, guidelines, and trials listed above. Findings reflect each source’s own populations, materials, and test conditions.
Compiled on . Verify against current evidence and apply professional judgment before clinical use.